Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/22820
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMAEREMANS, Joren-
dc.contributor.authorWalsh, Simon-
dc.contributor.authorKnaapen, Paul-
dc.contributor.authorSpratt, James C.-
dc.contributor.authorAvran, Alexandre-
dc.contributor.authorHanratty, Colm G.-
dc.contributor.authorFaurie, Benjamin-
dc.contributor.authorAgostoni, Pierfrancesco-
dc.contributor.authorBressollette, Erwan-
dc.contributor.authorKayaert, Peter-
dc.contributor.authorBagnall, Alan J.-
dc.contributor.authorEgred, Mohaned-
dc.contributor.authorSmith, Dave-
dc.contributor.authorChase, Alexander-
dc.contributor.authorMcEntegart, Margaret B.-
dc.contributor.authorSmith, William H. T.-
dc.contributor.authorHarcombe, Alun-
dc.contributor.authorKelly, Paul-
dc.contributor.authorIrving, John-
dc.contributor.authorSmith, Elliot J.-
dc.contributor.authorStrange, Julian W.-
dc.contributor.authorDENS, Jo-
dc.date.accessioned2016-12-01T10:33:12Z-
dc.date.available2016-12-01T10:33:12Z-
dc.date.issued2016-
dc.identifier.citationJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 68(18), p. 1958-1970-
dc.identifier.issn0735-1097-
dc.identifier.urihttp://hdl.handle.net/1942/22820-
dc.description.abstractBACKGROUND The hybrid algorithm for chronic total occlusion (CTO) percutaneous coronary intervention (PCI) was developed to improve procedural outcomes. Large, prospective studies validating the algorithm in a broad multicenter setting with operators of different experience levels are lacking. OBJECTIVES The RECHARGE (REgistry of Crossboss and Hybrid procedures in FrAnce, the NetheRlands, BelGium and UnitEd Kingdom) registry aims to report achievable results using the hybrid algorithm. METHODS Between January 2014 and October 2015, consecutive patients undergoing hybrid CTO-PCI were prospectively enrolled in 17 centers. Procedural techniques, outcomes, and in-hospital complications were analyzed. RESULTS A total of 1,253 CTO-PCIs were performed in 1,177 patients, of which 86% were men. Mean age was 66 +/- 11 years. The average Japanese CTO score was 2.0 +/- 1.0, and was higher in the failure group (2.6 +/- 0.6 vs. 1.9 +/- 1.0; p < 0.001). Overall procedure success was 86% and major in-hospital complications occurred in 2.6%. Antegrade wire escalation was the preferred primary strategy in 77%, followed by retrograde (17%) and antegrade dissection re-entry strategies (7%). Primary strategies were successful in 60%. Consecutive strategies were applied in 34% and were successful in 74%. Antegrade dissection re-entry and retrograde strategies were the most common bailout strategies and were successful in 67% and 62%, respectively. Median procedure and fluoroscopy time were 90 (interquartile range [ IQR]: 60 to 120) min and 35 (IQR: 21 to 55) min, contrast volume was 250 (IQR: 180 to 340) ml, and radiation doses (air kerma and dose area product) were 1.6 (IQR: 1.0 to 2.7) Gy and 98 (IQR: 57 to 168) Gy.cm(2), respectively. CONCLUSIONS High procedure and patient success rates, combined with a low event rate and improved procedural characteristics, support further use of the hybrid algorithm for a broad community of appropriately trained CTO operators.-
dc.description.sponsorshipThis research project is supported by a research grant from Boston Scientific (Marlborough, Massachusetts). Dr. Maeremans is researcher for the Limburg Clinical Research Program UHasselt-ZOL-Jessa, supported by the foundation Limburg Sterk Merk, Hasselt University, Ziekenhuis Oost-Limburg, and Jessa Hospital. Drs. Walsh has served as a consultant for Abbott Vascular, Boston Scientific, Medtronic, and Vascular Solutions; and has received research funding from Abbott Vascular, Boston Scientific, and Nitiloop. Drs. Knaapen, Spratt, and Bressollette have served as proctors for and received proctor honoraria from Boston Scientific. Dr. Avran has received grants from Abbott Vascular, Boston Scientific, and Biosensor for teaching courses and proctoring. Dr. Hanratty has served as consultant for Abbott Vascular, Boston Scientific, Medtronic, and Vascular Solutions. Dr. Faurie has served as a proctor for Boston Scientific; and as a consultant for CORDIS. Dr. Bagnall has received proctor and speaker fees from Abbott Vascular and AstraZeneca. Dr. Egred has served as a proctor for and received honoraria from Boston Scientific, Abbott Vascular, Vascular Perspectives, Volcano, and Spectranetics. Dr. Elliot Smith has served as a proctor for Boston Scientific; and received honoraria from Vascular Solutions, Abbott Vascular, Vascular Perspectives, and Cardi Red. Dr. Kelly has served on the advisory boards of Boston Scientific and Abbott Vascular. Dr. Irving has served as a proctor for Boston Scientific and Vascular Perspectives. Dr. Dens has received grants from TopMedical (distributor of Asahi Intecc Co. Materials), Boston Scientific, and Orbus Neich for teaching courses and proctoring. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.-
dc.language.isoen-
dc.publisherELSEVIER SCIENCE INC-
dc.rights(C) 2016 by the American College of Cardiology Foundation-
dc.subject.otherchronic total occlusion; hybrid; percutaneous coronary intervention-
dc.subject.otherchronic total occlusion; hybrid; percutaneous coronary intervention-
dc.titleThe Hybrid Algorithm for Treating Chronic Total Occlusions in Europe The RECHARGE Registry-
dc.typeJournal Contribution-
dc.identifier.epage1970-
dc.identifier.issue18-
dc.identifier.spage1958-
dc.identifier.volume68-
local.format.pages13-
local.bibliographicCitation.jcatA1-
dc.description.notes[Maeremans, Joren; Dens, Joseph] Univ Hasselt, Fac Med & Life Sci, Hasselt, Belgium. [Maeremans, Joren; Dens, Joseph] Ziekenhuis Oost Limburg, Dept Cardiol, Schiepse Bos 6, B-3600 Genk, Belgium. [Walsh, Simon; Hanratty, Colm G.] Belfast City Hosp, Dept Cardiol, Belfast, Antrim, North Ireland. [Knaapen, Paul] Vrije Univ Amsterdam, Med Ctr, Dept Cardiol, Amsterdam, Netherlands. [Spratt, James C.] Forth Valley Royal Hosp, Dept Cardiol, Edinburgh, Midlothian, Scotland. [Avran, Alexandre] Clin Marignane, Dept Cardiol, Marignane, France. [Faurie, Benjamin] Grp Hosp Mutualiste, Dept Cardiol, Grenoble, France. [Agostoni, Pierfrancesco] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands. [Agostoni, Pierfrancesco] St Antonius Hosp, Dept Cardiol, Nieuwegein, Netherlands. [Bressollette, Erwan] Nouvelles Clin Nantaises, Dept Cardiol, Nantes, France. [Kayaert, Peter] Univ Ziekenhuis Brussel, Dept Cardiol, Brussels, Belgium. [Bagnall, Alan J.; Egred, Mohaned] Freeman Rd Hosp, Dept Cardiol, Newcastle Upon Tyne, Tyne & Wear, England. [Bagnall, Alan J.; Egred, Mohaned] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England. [Smith, Dave; Chase, Alexander] Morriston Hosp, Dept Cardiol, Swansea, W Glam, Wales. [McEntegart, Margaret B.] Golden Jubilee Natl Hosp, Dept Cardiol, Glasgow, Lanark, Scotland. [Smith, William H. T.; Harcombe, Alun] Univ Nottingham Hosp, Dept Cardiol, Nottingham, England. [Kelly, Paul] Basildon Hosp, Essex Cardiothorac Ctr, Dept Cardiol, Basildon, Essex, England. [Irving, John] Ninewells Hosp, Dept Cardiol, Dundee, Scotland. [Smith, Elliot J.] Barts Hlth NHS Trust, Barts Heart Ctr, Dept Cardiol, London, England. [Strange, Julian W.] Bristol Heart Inst, Dept Cardiol, Bristol, Avon, England.-
local.publisher.placeNEW YORK-
local.type.refereedRefereed-
local.type.specifiedArticle-
local.classdsPublValOverrule/author_version_not_expected-
dc.identifier.doi10.1016/j.jacc.2016.08.034-
dc.identifier.isi000386828100005-
item.validationecoom 2017-
item.accessRightsRestricted Access-
item.fullcitationMAEREMANS, Joren; Walsh, Simon; Knaapen, Paul; Spratt, James C.; Avran, Alexandre; Hanratty, Colm G.; Faurie, Benjamin; Agostoni, Pierfrancesco; Bressollette, Erwan; Kayaert, Peter; Bagnall, Alan J.; Egred, Mohaned; Smith, Dave; Chase, Alexander; McEntegart, Margaret B.; Smith, William H. T.; Harcombe, Alun; Kelly, Paul; Irving, John; Smith, Elliot J.; Strange, Julian W. & DENS, Jo (2016) The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe The RECHARGE Registry. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 68(18), p. 1958-1970.-
item.fulltextWith Fulltext-
item.contributorMAEREMANS, Joren-
item.contributorWalsh, Simon-
item.contributorKnaapen, Paul-
item.contributorSpratt, James C.-
item.contributorAvran, Alexandre-
item.contributorHanratty, Colm G.-
item.contributorFaurie, Benjamin-
item.contributorAgostoni, Pierfrancesco-
item.contributorBressollette, Erwan-
item.contributorKayaert, Peter-
item.contributorBagnall, Alan J.-
item.contributorEgred, Mohaned-
item.contributorSmith, Dave-
item.contributorChase, Alexander-
item.contributorMcEntegart, Margaret B.-
item.contributorSmith, William H. T.-
item.contributorHarcombe, Alun-
item.contributorKelly, Paul-
item.contributorIrving, John-
item.contributorSmith, Elliot J.-
item.contributorStrange, Julian W.-
item.contributorDENS, Jo-
crisitem.journal.issn0735-1097-
crisitem.journal.eissn1558-3597-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
maeremans 1.pdf
  Restricted Access		Published version1.35 MBAdobe PDFView/Open    Request a copy
Figure_1_DENS_JACC.tif
  Restricted Access		Supplementary material6.46 MBTIFFView/Open    Request a copy
Figure_2_DENS_JACC.tif
  Restricted Access		Supplementary material11.41 MBTIFFView/Open    Request a copy
Central_illustration_DENS_JACC.tif
  Restricted Access		Supplementary material33.3 MBTIFFView/Open    Request a copy
Show simple item record

SCOPUSTM   
Citations

115
checked on Sep 3, 2020

WEB OF SCIENCETM
Citations

213
checked on May 8, 2024

Page view(s)

22
checked on Aug 10, 2022

Download(s)

6
checked on Aug 10, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.